{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Medicare", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Obama, Barack", "name": "persons", "rank": "4", "is_major": "N"}, {"value": "Patient Protection and Affordable Care Act (2010)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Health and Human Services Department", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Burwell, Sylvia Mathews", "name": "persons", "rank": "7", "is_major": "N"}, {"value": "Medicare", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Health Insurance and Managed Care", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Patient Protection and Affordable Care Act (2010)", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Obama, Barack", "name": "persons", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/10/us/politics/groups-scrutinize-white-house-plan-to-cut-drug-costs-in-medicare.html", "document_type": "article", "byline": {"person": [{"lastname": "PEAR", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}], "original": "By ROBERT PEAR"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/10/us/10drugsweb/10drugsweb-thumbWide.jpg", "legacy": {"wide": "images/2016/03/10/us/10drugsweb/10drugsweb-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/10/us/10drugsweb/10drugsweb-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/10/us/10drugsweb/10drugsweb-articleLarge.jpg", "xlargeheight": "408", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 408}, {"url": "images/2016/03/10/us/10drugsweb/10drugsweb-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/10/us/10drugsweb/10drugsweb-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "U.S.", "word_count": "900", "source": "The New York Times", "subsection_name": "Politics", "lead_paragraph": "The Obama administration touched off a tempest with its plan to test new ways of paying for prescription drugs under Medicare.", "pub_date": "2016-03-10T00:00:00Z", "news_desk": "National", "headline": {"print_headline": "Plan to Cut Drug Costs in Medicare Is Scrutinized", "main": "Groups Scrutinize White House Plan to Cut Drug Costs in Medicare"}, "print_page": "10", "snippet": "The Obama administration touched off a tempest with its plan to test new ways of paying for prescription drugs under Medicare.", "_id": "56e0d38c38f0d80718d5617a", "slideshow_credits": null, "abstract": "Obama administration's plan to test new ways to pay for prescription drugs under Medicare sets off flurry of responses, some critical, from drug manufacturers, representatives of Medicare beneficiaries and lawmakers; proposal, while only in test phase, carries major implications for pharmaceutical industry."}